JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1426
MGM Resorts International
MGM
$7.59B
| $42.9M | ﹤0.01% |
1,237,820
-217,456
| -15% | -$8.22M |
2013 Q2
46 quarters
|
|
|
SCHW
1427
PUT
Charles Schwab
SCHW
$169B
| $42.9M | ﹤0.01% |
579,000
+245,000
| +73% | +$18.3M |
2021 Q1
15 quarters
|
|
1428
PUT
Chipotle Mexican Grill
CMG
$39B
| $42.5M | ﹤0.01% |
705,000
-185,000
| -21% | -$11.1M |
2021 Q3
13 quarters
|
|
1429
Annaly Capital Management
NLY
$13.8B
| $42.4M | ﹤0.01% |
2,316,776
-740,261
| -24% | -$14.5M |
2013 Q2
46 quarters
|
|
1430
CALL
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$114M
| $42.4M | ﹤0.01% |
1,600,000
+1,500,000
| +1,500% | +$38.8M |
2024 Q3
1 quarter
|
|
1431
Hormel Foods
HRL
$11.1B
| $42.3M | ﹤0.01% |
1,347,038
+47,705
| +4% | +$1.5M |
2013 Q2
46 quarters
|
|
1432
Tenet Healthcare
THC
$20.9B
| $41.9M | ﹤0.01% |
332,023
-26,473
| -7% | -$3.94M |
2013 Q2
46 quarters
|
|
1433
Pathward Financial
CASH
$1.53B
| $41.9M | ﹤0.01% |
569,238
+195,331
| +52% | +$14.9M |
2015 Q2
38 quarters
|
|
1434
NexGen Energy
NXE
$6.08B
| $41.9M | ﹤0.01% |
6,345,726
+4,378,933
| +223% | +$33M |
2023 Q4
4 quarters
|
|
1435
CALL
Alibaba
BABA
$276B
| $41.8M | ﹤0.01% |
492,400
+14,900
| +3% | +$1.41M |
2014 Q4
40 quarters
|
|
1436
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.55B
| $41.7M | ﹤0.01% |
1,034,606
+17,508
| +2% | +$735K |
2022 Q1
11 quarters
|
|
1437
PUT
CF Industries
CF
$17.6B
| $41.6M | ﹤0.01% |
487,800
-64,300
| -12% | -$5.56M |
2023 Q4
4 quarters
|
|
1438
iShares Biotechnology ETF
IBB
$11B
| $41.6M | ﹤0.01% |
314,398
-256,444
| -45% | -$36.1M |
2013 Q2
46 quarters
|
|
1439
TCW Transform 500 ETF
VOTE
$1.14B
| $41.5M | ﹤0.01% |
602,943
-37,643
| -6% | -$2.6M |
2022 Q4
8 quarters
|
|
1440
iShares U.S. Carbon Transition Readiness Aware Active ETF
LCTU
$1.19B
| $41.4M | ﹤0.01% |
647,020
+43,768
| +7% | +$2.82M |
2022 Q4
8 quarters
|
|
1441
CALL
Coupang
CPNG
$25.5B
| $41.2M | ﹤0.01% |
1,876,700
| – | – |
2024 Q1
3 quarters
|
|
1442
Cabot Corp
CBT
$4B
| $41.2M | ﹤0.01% |
451,513
+96,179
| +27% | +$10.3M |
2013 Q2
46 quarters
|
|
1443
Novartis
NVS
$268B
| $41.2M | ﹤0.01% |
423,142
+111,066
| +36% | +$11.8M |
2013 Q2
46 quarters
|
|
1444
Ally Financial
ALLY
$11.4B
| $41.2M | ﹤0.01% |
1,143,350
-8,453
| -0.7% | -$307K |
2014 Q2
42 quarters
|
|
|
INFA
1445
DELISTED
Informatica
INFA
| $41.1M | ﹤0.01% |
1,584,163
+100,016
| +7% | +$2.62M |
2021 Q4
12 quarters
|
|
1446
Idacorp
IDA
$7.62B
| $41M | ﹤0.01% |
375,522
+32,122
| +9% | +$3.53M |
2013 Q2
46 quarters
|
|
1447
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.4B
| $41M | ﹤0.01% |
1,471,079
-1,337
| -0.1% | -$37.8K |
2017 Q4
28 quarters
|
|
1448
CALL
Spotify
SPOT
$99.3B
| $41M | ﹤0.01% |
91,600
+56,400
| +160% | +$24.2M |
2024 Q1
3 quarters
|
|
1449
iShares International Equity Factor ETF
INTF
$3.7B
| $40.9M | ﹤0.01% |
1,425,417
+1,334,188
| +1,462% | +$40M |
2022 Q4
8 quarters
|
|
1450
CALL
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.5B
| $40.8M | ﹤0.01% |
363,800
+58,200
| +19% | +$6.22M |
2023 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.